Stem cell selection in vivo using foamy vectors cures canine pyruvate kinase deficiency

Hematopoietic stem cell (HSC) gene therapy has cured immunodeficiencies including X-linked severe combined immunodeficiency (SCID-X1) and adenine deaminase deficiency (ADA). For these immunodeficiencies corrected cells have a selective advantage in vivo, and low numbers of gene-modified cells are su...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2012-09, Vol.7 (9), p.e45173-e45173
Hauptverfasser: Trobridge, Grant D, Beard, Brian C, Wu, Robert A, Ironside, Christina, Malik, Punam, Kiem, Hans-Peter
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!